Latest Wire — May 7, 2026
Earnings
Angelini Pharma's $4.1 Billion Acquisition of Catalyst Pharmaceuticals: What It Means for the US Market
Angelini Pharma's $4.1 billion acquisition of Catalyst Pharmaceuticals marks a strategic move into the US biotech market, focusing on brain health and rare diseases.
Sarah Chen • May 7
READ FULL STORY →
Markets
Devon Energy and Coterra Energy Merger: A New Era in Shale Oil Production
The merger of Devon Energy and Coterra Energy signals a significant shift in the shale oil landscape…
James McAllister • May 7
READ →